1. Introduction {#sec1}
===============

Hypertension is a major cardiovascular risk factor worldwide. Projections are that, by the year of 2025, 75.0% (or 1.17 billion people) of the people with hypertension in the world will be living in emerging nations \[[@B1]\]. In Brazil, about 29% of the Brazilian population has hypertension \[[@B2]\]. Alcohol abuse is associated with elevated blood pressure \[[@B3]\], regardless of other risk factors \[[@B4]--[@B6]\]. Different studies have shown prevalence rates of hypertension attributed to alcohol consumption ranging from 5 to 30% \[[@B7]\].

Risk factors for cardiovascular diseases, including hypertension and dyslipidemia, are determinants of reduced life expectancy in HIV-infected patients \[[@B8]\]. Hypertension prevalence in HIV-infected individuals ranges from 5.9 to 56.4% \[[@B9]--[@B12]\] and has been associated with alcohol abuse and other factors related to HIV infection \[[@B9], [@B10], [@B13]\]. In these individuals, the prevalence of alcohol abuse ranges from 8% \[[@B14], [@B15]\] to 50% \[[@B16]--[@B18]\], exceeding the rates in general populations of the United States \[[@B19]\], Europe \[[@B20]\], and Brazil \[[@B21]\], where the prevalence is between 2 and 41% in men and 0.1 and 21% in women \[[@B20]\].

The relationship between alcohol consumption and hypertension may be influenced by some characteristics, such as skin color \[[@B3], [@B22]\]. Skin color has been identified as a marker of lifestyle \[[@B3], [@B23], [@B24]\] and, in some countries, it may also be characterized as the socioeconomic status of the individuals \[[@B4]\]. In Brazil, the HIV-infected population tends to be more homogeneous in terms of socioeconomic status, affecting the less privileged ones. High blood pressure has been associated with low socioeconomic status \[[@B4]\] and skin color may also be a risk factor. Therefore, the objective of the present study was to investigate if the association between alcohol abuse, blood pressure, and hypertension in HIV-infected patients is influenced by skin color.

2. Materials and Methods {#sec2}
========================

We conducted a cross-sectional study including HIV-infected individuals who were being followed up at the Outpatient Clinic of the Care and Therapy Service (SAT), Hospital Sanatório Partenon, State Department of Health of Rio Grande do Sul, Brazil. This clinic and all public health care centers provide medical care, antiretroviral therapy (ART), antihypertensives, and other medications free of charge for HIV-infected patients. We consecutively enrolled female and male patients, aged 18 or older, who were seen between June 2006 and December 2008. Pregnant women, individuals who were unable to provide written consent, or those incarcerated were excluded. Participants who were under the influence of alcohol or drugs at the time of the interview were asked to return for evaluation at another time.

Participants were interviewed on the day of the regular medical appointments. Since they had to consult every month, in order to get antiretroviral medication, they were seen often, which contributed to achieving high participation rate. Information was collected, using standardized questionnaires, for the following characteristics: demographic (age and skin color self-reported, classified as white or nonwhite), socioeconomic (educational attainment, number of school years), and lifestyle characteristics (alcohol consumption, physical activity, and smoking), as well as the use of antiretroviral therapy (ART), and time since diagnosis of HIV infection (in years, classified as ≥6 years, from 3.0 to 5.9 years, and \<3 years). Data related to HIV infection as CD4 lymphocyte count (mm^3^/mL), viral load (copies per mL of blood), and clinical information were confirmed by medical records. Alcohol consumption was investigated using a validated quantity-frequency questionnaire based on the kind of beverage consumed \[[@B21]\], administered by a physician or healthcare professional, containing questions about type, frequency, and amount of alcohol consumed in the last six months. Alcohol consumption was categorized into abstemious drinking, social drinking (\>0 and \<15 grams/day for women and \>0 and \<30 grams/day for men), or abusive drinking (≥15 grams/day for women and ≥30 grams/day for men) \[[@B21], [@B22], [@B25]\]. Binge drinking was characterized by a consumption of five or more drinks on a single occasion \[[@B22]\]. Frequency of consumption was classified as weekly (consumption on some days of the week, but not daily) or monthly (consumption on some days of the month but not every week), regardless of the amount. Physical activity was investigated using the IPAQ (International Physical Activity Questionnaire) \[[@B26]\], which investigates frequency and duration of physical activity. The intensity of exercise was classified as moderate or high versus low physical activity according to the IPAQ protocol \[[@B27]\]. Smoking was defined according to the information provided by the participants, classifying the amount of consumption in at least 100 cigarettes during their lifetimes.

Weight (Kg) and height (m) were measured twice with the participants being barefoot and wearing light clothes, using an anthropometric scale (Filizola, model 31 adult, Indústria Filizola S.A., São Paulo, SP, Brazil). Body mass index (BMI; kg/m^2^) was calculated as the weight (kg) divided by the square of the height (m) and classified as normal (\<25.0), overweight (25--29.9), and obesity (≥30.0). Standardized measurements of blood pressure were obtained in duplicate in two visits, using a validated oscillometric device (OMRON CP-705) \[[@B28]\]. The average of four BP measurements was used to detect hypertension if systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg, or in use of blood pressure-lowering agents \[[@B25]\].

Certified researchers performed the interviews and measured anthropometric parameters and blood pressure. Approximately 5% of the interviews were repeated for quality control. Data were entered twice into the database of Epinfo, version 2000. The study was approved by the Research Ethics Committee of the Hospital de Clínicas de Porto Alegre, which is accredited by the Office of Human Research Protections. All participants signed an informed consent form.

*Sample Size Calculation and Statistical Analysis*. Sample size calculation was based on the estimated prevalence of hypertension between white and nonwhite participants with abusive alcohol consumption (30 and 35%, resp.) and abstemious drinking (18%), with 80% of power and a significance level of 0.05 (two-tailed). A sample size of 738 white and 398 nonwhite participants with a 1 : 5 ratio for exposed and unexposed participants to excessive alcohol consumption would be required to detect a hazard ratio of at least 1.7. The estimates were based on previous studies \[[@B22], [@B29]\].

Characteristics of the sample were expressed as mean and standard deviation. We used Pearson\'s chi-square test for the analysis of categorical variables and analysis of variance (continuous variables) to assess the association between these factors and the different outcomes. Confounding factors were controlled using the modified Poisson regression (robust variance estimates) \[[@B30]\] and analysis of covariance. Statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS Inc., Chicago, Illinois, USA), version 18.0. Confounding factors were selected based on the literature \[[@B3], [@B31], [@B32]\] and *P* values lower than or equal to 0.2 in unadjusted analysis. Age, sex, educational attainment, smoking, physical activity, body mass index, time since HIV infection, and lifetime HAART use were considered confounding factors used in the multivariate models for whites and nonwhites. Partially adjusted models of alcohol consumption with systolic or diastolic blood pressure, including age, sex, and educational attainment, were run in order to better understand the associations and to interpret the risk ratios. A trend for association was determined by *P* values between 0.05 and 0.1.

3. Results {#sec3}
==========

Of the 1,295 HIV-infected patients screened, 1,255 were eligible and 1,240 were included. Thus, forty patients had not confirmed eligibility due to age under 18 years, incarceration, or pregnancy; fifteen refused to participate, and two patients were included in a second attempt due to alcohol intoxication at the first visit. Characteristics of the overall sample are presented in [Table 1](#tab1){ref-type="table"} by skin color. Participants were aged 39.1 ± 10, half of them were males, and 57% had white skin color. Overall, the distribution of most characteristics was similar among whites and nonwhites, but whites had higher education and time since HIV infection, and nonwhites had high physical activity and prevalence of hypertension.

Risk factors for hypertension among whites and nonwhites are shown in [Table 2](#tab2){ref-type="table"}. The unadjusted analysis showed that only age and BMI were positively associated with hypertension for both categories of skin color. White smokers had lower prevalence of hypertension, whereas among nonwhites there was a trend for the association of alcohol abuse with hypertension. There was no association between variables related to HIV and hypertension.

[Table 3](#tab3){ref-type="table"} shows that association among the different patterns of alcoholic beverages consumption is roughly similar in whites and nonwhites; abusive consumption of alcohol was associated with hypertension in white and nonwhite HIV-infected individuals, independently of a large set of confounding variables. The frequency of alcohol consumption and acute intake of large amounts were not associated with hypertension.

Systolic and diastolic blood pressure was higher exclusively in nonwhite participants who abused alcohol, independently of confounding factors ([Table 4](#tab4){ref-type="table"}). Systolic blood pressure was on average 9.3 ± 3.2 mmHg, and diastolic 6.4 ± 2.1 mmHg greater among abusers. These differences were independent of age, sex, and educational attainment (data not shown) and of full control for confounding factors. Among white participants, there were an association of diastolic blood pressure with weekly consumption of alcoholic beverages in comparison with nondrinkers and a borderline association versus monthly consumers.

4. Discussion {#sec4}
=============

In this study, we found that the consumption of large amounts of alcohol was independently associated with hypertension in white and nonwhite HIV-infected individuals. Blood pressure, on the other hand, was higher exclusively in nonwhite abusers of ethanol, demonstrated after adjustment for confounding factors. However, even partially adjusted models showed the presence of negative confounding factors. Among, whites there was an association of blood pressure with the frequency of consumption. Taken together, these findings suggest that among nonwhite participants quantity is more important than the pattern of consumption, while for whites the frequency of drinking is more relevant.

The association between alcohol abuse and hypertension identified in our study is in agreement with findings from other populations \[[@B33]\]. The association of blood pressure with abusive consumption exclusively in nonwhites was similar to the observed one in the ARIC cohort study (Atherosclerosis Risk in Communities) \[[@B3]\] and in a cohort carried out in southern Brazil \[[@B22]\]. It is unlikely that this differential association of alcohol abuse and blood pressure by skin color is due to race or ethnicity, but probably relies on other behavioral characteristics of nonwhite individuals \[[@B34]\]. Anyway, blood pressure was higher exclusively in nonwhite abusers, suggesting that these individuals are at higher risk of the harmful effects of ethanol.

Our study adds a piece of mind in the investigation of the influence of HIV-related characteristics and higher incidence of cardiovascular disease. It has been suggested that the use of HAART may be associated with increasing blood pressure \[[@B9], [@B10], [@B35], [@B36]\]. In some studies, longer time of HAART was associated with hypertension \[[@B13], [@B37]\]. These associations were not identified in our study, since the use of antiretrovirals, time of HIV infection, AIDS, and CD4 count were not associated with hypertension.

Some limitations of our study deserve to be mentioned. The cross-sectional design does not allow inferring causality. Data on alcohol consumption were obtained from a standardized questionnaire containing detailed information, but it relies on memory, and because it was applied in the context of medical care, this might have led individuals to underreport consumption. Another aspect to be considered is the fact that blood pressure measurements were performed at the medical consultation, and therefore the possibility of a white coat effect cannot be discarded. Even underreporting alcohol consumption or the white coat effect, the association of alcohol abuse with hypertension has been confirmed by ambulatory monitoring of blood pressure \[[@B38]\]. The prospective planning, together with the extensive and detailed measurement of AIDS-related and nonrelated characteristics and adequate statistical power, is a strength of our investigation.

5. Conclusions {#sec5}
==============

In conclusion, alcohol abuse is associated with increased risk of hypertension in white and nonwhite HIV-infected individuals. Blood pressure is higher only in nonwhite individuals who abuse alcoholic beverages and in whites who drink weekly. The association of ethanol consumption with blood pressure is not explained by AIDS-related conditions.
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###### 

Characteristics of HIV-infected individuals according to skin color (*n* (%) or mean ± SD).

                                     Total (*n* = 1240)   Whites (*n* = 710)   Nonwhites (*n* = 530)   *P* value
  ---------------------------------- -------------------- -------------------- ----------------------- -----------
  Male                               628 (50.6)           391 (55.1)           237 (44.7)              \<0.001
  Age (years)                        39.1 ± 10.0          39.3 ± 10.3          38.9 ± 9.7              0.5
  Educational attainment (years)     7.5 ± 4.1            8.3 ± 4.2            6.4 ± 3.7               \<0.001
  Smoking                            525 (42.3)           298 (42.0)           227 (42.8)              0.4
  Physical activity                                                                                    0.049
   Low                               321 (25.9)           199 (28.0)           122 (23.0)               
   Moderate                          398 (32.1)           232 (32.7)           166 (31.3)               
   High                              521 (42.0)           279 (39.3)           242 (45.7)               
  Alcohol consumption                                                                                  0.7
   Abstemious                        414 (33.4)           233 (32.8)           181 (34.2)               
   Social drinking                   757 (61.0)           440 (62.0)           317 (59.8)               
   Abusive drinking                  69 (5.6)             37 (5.2)             32 (6.0)                 
  Frequency of alcohol consumption                                                                     0.7
   Abstemious                        414 (33.4)           233 (32.8)           181 (34.2)               
   Monthly                           440 (35.5)           249 (35.1)           191 (36.0)               
   Weekly                            386 (31.1)           228 (32.1)           158 (29.8)               
  Binge drinking                     211 (17.0)           117 (55.5)           94 (44.5)               0.7
   Abstemious                        414 (33.4)           233 (32.8)           181 (34.2)               
   No                                616 (49.7)           360 (50.7)           255 (48.1)               
   Yes                               210 (16.9)           117 (16.5)           94 (17.7)                
  Body mass index (kg/m²)            24.9 ± 4.4           24.8 ± 4.3           25.0 ± 4.7              0.4
  Systolic blood pressure (mmHg)     121.8 ± 18.2         121.8 ± 17.7         121.8 ± 18.8            0.9
  Diastolic blood pressure (mmHg)    76.6 ± 11.4          76.0 ± 10.7          77.3 ± 12.3             0.06
  Hypertension                       241 (19.4)           120 (16.9)           121 (22.8)              0.009
  Time since HIV infection (years)                                                                     0.005
   ≥6.0                              404 (32.6)           250 (35.3)           154 (29.1)               
   3.0--5.9                          350 (28.2)           176 (24.8)           174 (32.8)               
   \<3.0                             485 (39.1)           283 (39.9)           202 (38.1)               
  HIV/HCV coinfection                261 (22.2)           143 (21.2)           118 (23.5)              0.3
  AIDS diagnosis                     892 (72.2)           510 (72.0)           382 (72.3)              0.9
  Lifetime HAART use                 815 (65.7)           467 (65.8)           348 (65.7)              0.9
  Lifetime protease inhibitor use    468 (37.7)           277 (39.0)           191 (36.0)              0.3
  CD4 (cell/mm^3^)                                                                                     0.08
   \<350                             476 (38.8)           258 (36.7)           218 (41.6)               
   ≥350                              751 (61.2)           445 (63.3)           306 (58.4)               

HAART: highly active antiretroviral therapy; HCV: hepatitis C virus; HIV: human immunodeficiency virus; SD: standard deviation.

###### 

Risk factors for hypertension among HIV-infected individuals by skin color (*n* (%)).

                                     Whites (*n* = 710)   Nonwhites (*n* = 530)               
  ---------------------------------- -------------------- ----------------------- ----------- ----------------
  Sex                                                                                          
   Female                            48 (15.0)            1.0                     65 (22.2)   1.0
   Male                              72 (18.4)            1.2 (0.9--1.7)          56 (23.6)   1.1 (0.8--1.5)
    *P* value                                             0.2                                 0.7
  Age (years)                                                                                  
   18--34                            20 (7.4)             1.0                     23 (11.4)   1.0
   35--49                            56 (16.9)            2.3 (1.4--3.7)          63 (24.3)   2.1 (1.4--3.3)
   50--78                            44 (40.4)            5.4 (3.4--8.8)          35 (50.7)   4.5 (2.8--7.0)
    *P* value                                             \<0.001                             \<0.001
  Educational attainment (years)                                                               
   ≥9                                58 (17.8)            1.0                     23 (17.8)   1.0
   5--8                              38 (16.2)            0.9 (0.6--1.3)          51 (22.2)   1.2 (0.8--1.9)
   0--4                              24 (16.0)            0.9 (0.6--1.4)          47 (27.5)   1.5 (1.0--2.4)
    *P* value                                             0.8                                 0.14
  Smoking                                                                                      
   No                                85 (20.6)            1.0                     76 (25.1)   1.0
   Yes                               35 (11.7)            0.6 (0.4--0.8)          45 (19.8)   0.8 (0.6--1.1)
    *P* value                                             0.002                               0.16
  Physical activity                                                                            
   High                              39 (14.0)            1.0                     48 (19.8)   1.0
   Moderate                          44 (19.0)            1.4 (0.9--2.0)          38 (22.9)   1.2 (0.8--1.7)
   Low                               37 (18.6)            1.3 (0.9--2.0)          35 (28.7)   1.4 (1.0--2.1)
    *P* value                                             0.3                                 0.16
  Alcohol consumption                                                                          
   Abstemious                        41 (17.6)            1.0                     41 (22.7)   1.0
   Social drinking                   70 (15.9)            0.9 (0.6--1.3)          68 (21.5)   0.9 (0.7--1.3)
   Abusive drinking                  9 (24.3)             1.4 (0.7--2.6)          12 (37.5)   1.7 (1.0--2.8)
    *P* value                                             0.4                                 0.08
  Frequency of alcohol consumption                                                             
   Abstemious                        41 (18.0)            1.0                     41 (22.7)   1.0
   Monthly                           41 (17.6)            0.9 (0.6--1.3)          42 (26.6)   0.9 (0.6--1.3)
   Weekly                            38 (15.3)            1.1 (0.7--1.5)          79 (21.2)   1.2 (0.8--1.7)
    *P* value                                             0.7                                 0.3
  Binge drinking                                                                               
   Abstemious                        41 (17.6)            1.0                     41 (22.7)   1.0
   No                                60 (16.7)            0.9 (0.7--1.4)          60 (23.4)   1.0
   Yes                               19 (16.2)            0.9 (0.6--1.5)          20 (21.5)   1.0 (0.6--1.5)
    *P* value                                             0.9                                 0.8
  Body mass index (kg/m²)                                                                      
   \<25.0                            36 (8.7)             1.0                     45 (15.3)   1.0
   25--29.9                          58 (26.6)            3.1 (2.1--4.5)          40 (24.7)   1.6 (1.1--2.4)
   ≥30.0                             26 (32.9)            3.8 (2.4--5.9)          36 (49.3)   3.2 (2.3--4.6)
    *P* value                                             \<0.001                             \<0.001
  HIV/HCV coinfection                                                                          
   No                                96 (18.0)            1.0                     85 (22.1)   1.0
   Yes                               22 (15.4)            0.9 (0.6--1.3)          29 (24.6)   1.1 (0.8--1.6)
    *P* value                                             0.5                                 0.6
  AIDS diagnosis                                                                               
   No                                29 (14.6)            1.0                     36 (24.7)   1.0
   Yes                               90 (17.6)            0.8 (0.6--1.2)          84 (22.0)   1.1 (0.8--1.6)
    *P* value                                             0.3                                 0.5
  Time since HIV infection (years)                                                             
   \<3.0                             47 (16.6)            1.0                     44 (21.8)   1.0
   3.0--5.9                          23 (13.1)            0.8 (0.5--1.2)          34 (19.5)   0.9 (0.6--1.3)
   ≥6.0                              50 (20.0)            1.2 (0.8--1.7)          43 (27.9)   1.3 (0.9--1.8)
    *P* value                                             0.18                                0.17
  Lifetime HAART use                                                                           
   No                                34 (14.0)            1.0                     46 (25.3)   1.0
   Yes                               86 (18.4)            1.3 (0.9--1.9)          75 (21.6)   0.9 (0.6--1.2)
    *P* value                                             0.14                                0.3
  Lifetime protease inhibitor use                                                              
   No                                77 (22.7)            1.0                     68 (15.7)   1.0
   Yes                               44 (23.0)            1.0 (0.7--1.4)          52 (18.8)   1.2 (0.9--1.7)
    *P* value                                             0.9                                 0.3
  CD4 (cell/mm^3^)                                                                             
   \<350                             39 (15.1)            1.0                     50 (22.9)   1.0
   ≥350                              80 (18.0)            0.8 (0.6--1.2)          69 (22.5)   1.0 (0.7--1.4)
    *P* value                                             0.3                                 0.9

HAART: highly active antiretroviral therapy; HCV: hepatitis C virus; HIV: human immunodeficiency virus; RR: risk ratio.

###### 

Association between alcohol consumption and hypertension according to skin color.

                                     Whites           Nonwhites
  ---------------------------------- ---------------- ----------------
  Alcohol consumption                                  
   Abstemious                        1.0              1.0
   Social drinking                   1.2 (0.8--1.7)   1.1 (0.8--1.5)
   Abusive drinking                  1.9 (1.1--3.3)   2.4 (1.4--4.0)
    *P* value                        0.09             0.004
  Frequency of alcohol consumption                     
   Abstemious                        1.0              1.0
   Monthly                           1.1 (0.7--1.6)   1.0 (0.7--1.5)
   Weekly                            1.4 (1.0--2.0)   1.3 (0.9--1.9)
    *P* value                        0.2              0.18
  Binge drinking                                       
   Abstemious                        1.0              1.0
   No                                1.2 (0.8--1.7)   1.1 (0.6--1.8)
   Yes                               1.2 (0.8--1.9)   1.2 (0.8--1.6)
    *P* value                        0.6              0.7

\*RR adjusted for age, sex, educational attainment, smoking, physical activity, BMI, time since diagnosis of HIV infection, and use of highly active antiretroviral therapy.

###### 

Association of systolic and diastolic blood pressure with alcohol consumption by skin color.

  Skin color              Alcohol consumption                BP ± SE (mmHg)   Delta of BP ± SE (mmHg)^∗†^   *P* value^∗†^   Delta of BP ± SE (mmHg)^∗∗†^   *P* value^∗∗†^
  ----------------------- ---------------------------------- ---------------- ----------------------------- --------------- ------------------------------ ----------------
  *Systolic BP (mmHg)*                                                                                                                                      
  Whites                  Abstemious                         120.5 ± 1.0      ---                                           ---                             
  Social drinking         122.5 ± 0.7                        2.0 ± 1.3        0.3                           ---                                            
  Abusive drinking        123.3 ± 2.5                        2.8 ± 2.8        0.7                           0.9 ± 2.7       1.0                            
  Nonwhites               Abstemious                         120.8 ± 1.3      ---                                           ---                             
  Social drinking         121.6 ± 0.9                        0.8 ± 1.6        0.9                           ---                                            
  Abusive drinking        130.9 ± 3.0                        10.1 ± 3.3       0.007                         9.3 ± 3.2       0.01                           
  *Diastolic BP (mmHg)*                                                                                                                                     
  Whites                  Abstemious                         74.9 ± 0.6       ---                                           ---                             
  Social drinking         76.6 ± 0.5                         1.7 ± 0.8        0.1                           ---                                            
  Abusive drinking        77.4 ± 1.6                         2.6 ± 1.7        0.4                           0.9 ± 1.7       0.9                            
  Nonwhites               Abstemious                         76.6 ± 0.9       ---                                           ---                             
  Social drinking         77.1 ± 0.6                         0.5 ± 1.1        0.9                           ---                                            
  Abusive drinking        83.4 ± 2.0                         6.9 ± 2.2        0.006                         6.4 ± 2.1       0.008                          
                                                                                                                                                           
                          Frequency of alcohol consumption                                                                                                  
                                                                                                                                                           
  *Systolic BP (mmHg)*                                                                                                                                      
  Whites                  Abstemious                         120.5 ± 1.0      ---                                                                           
  Monthly                 121.6 ± 1.0                        1.1 ± 1.4        0.9                           ---                                            
  Weekly                  123.5 ± 1.0                        3.0 ± 1.5        0.4                           2.3 ± 1.8       0.5                            
  Nonwhites               Abstemious                         120.8 ± 1.3      ---                                                                           
  Monthly                 121.3 ± 1.2                        0.5 ± 1.8        0.8                           ---                                            
  Weekly                  123.6 ± 1.4                        2.8 ± 2.0        0.12                          1.9 ± 1.4       0.5                            
  *Diastolic BP (mmHg)*                                                                                                                                     
  Whites                  Abstemious                         74.9 ± 0.6                                                                                     
  Monthly                 75.7 ± 0.6                         0.8 ± 0.9        0.8                                                                          
  Weekly                  77.6 ± 0.6                         2.8 ± 0.9        0.008                         2.0 ± 0.9       0.079                          
  Nonwhites               Abstemious                         76.7 ± 0.9                                                                                     
  Monthly                 77.5 ± 0.8                         0.8 ± 1.2        0.9                                                                          
  Weekly                  77.7 ± 0.9                         1.0 ± 1.3        0.8                           0.2 ± 1.2       0.9                            

SE: standard error; \*delta in relation to abstemious drinking; \*\*delta in relation to social drinking or monthly consumption; ^†^analyses of covariance adjusted for age, sex, educational attainment, smoking, physical activity, body mass index, time since HIV infection, and lifetime HAART use.
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